Other Species / Isoforms
  RHOC (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T19-p
GDGACGKtCLLIVFs
0 2
RHOC (human) GDGACGKtCLLIVFs T19-p
RHOC (mouse) GDGACGKtCLLIVFs T19-p
S26-p
tCLLIVFsKDQFPEV
0 2
RHOC (human) tCLLIVFsKDQFPEV S26-p
RHOC (mouse) tCLLIVFsKDQFPEV S26-p
Y34-p
KDQFPEVyVPTVFEN
Upstream
0 10
Treatment
  • imatinib
RHOC (human) KDQFPEVyVPTVFEN Y34-p
RHOC (mouse) KDQFPEVYVPTVFEN Y34
Y66-p
DTAGQEDyDRLRPLS
0 13
RHOC (human) DTAGQEDyDRLRPLS Y66-p
RHOC (mouse) DTAGQEDYDRLRPLS Y66
K104-ub
EKWTPEVkHFCPNVP
0 6
RHOC (human) EKWTPEVkHFCPNVP K104-ub
RHOC (mouse) EKWTPEVkHFCPNVP K104-ub
K118-ub
PIILVGNkkDLRQDE
0 6
RHOC (human) PIILVGNkkDLRQDE K118-ub
RHOC (mouse) PIILVGNkkDLRQDE K118-ub
K119-ub
IILVGNkkDLRQDEH
0 3
RHOC (human) IILVGNkkDLRQDEH K119-ub
RHOC (mouse) IILVGNkkDLRQDEH K119-ub
K135-ub
RRELAKMkQEPVRSE
0 7
RHOC (human) RRELAKMkQEPVRSE K135-ub
RHOC (mouse) RRELAKMkQEPVRSE K135-ub
S152-p
RDMANRIsAFGyLEC
0 2
RHOC (human) RDMANRIsAFGyLEC S152-p
RHOC (mouse) RDMANRISAFGYLEC S152
Y156-p
NRIsAFGyLECsAKT
0 4
RHOC (human) NRIsAFGyLECsAKT Y156-p
RHOC (mouse) NRISAFGYLECSAKT Y156
S160-p
AFGyLECsAKTKEGV
0 1
RHOC (human) AFGyLECsAKTKEGV S160-p
RHOC (mouse) AFGYLECSAKTKEGV S160